Blood pressure - Lowering for secondary prevention of stroke: ACE inhibition is the key

被引：3

作者：

Anderson, C ^{[1
]}

机构：

[1] Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand

来源：

STROKE | 2003年 / 34卷 / 05期

关键词：

angiotensin-converting enzyme inhibitors; blood pressure; stroke prevention;

D O I：

10.1161/01.STR.0000069266.99057.BF

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1333 / 1334

页数：2

共 10 条

[1] Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations [J].

Hankey, GJ ;

Warlow, CI .

LANCET, 1999, 354 (9188) :1457-1463

[2] Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Lindholm, LH ;

Ibsen, H ;

Dahlöf, B ;

Devereux, RB ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Julius, S ;

Kjeldsen, SE ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H ;

Aurup, P ;

Edelman, J ;

Snapinn, S .

LANCET, 2002, 359 (9311) :1004-1010

[3] EMERGING ROLE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN CARDIAC AND VASCULAR PROTECTION [J].

LONN, EM ;

YUSUF, S ;

JHA, P ;

MONTAGUE, TJ ;

TEO, KK ;

BENEDICT, CR ;

PITT, B .

CIRCULATION, 1994, 90 (04) :2056-2069

[4]

Lonn EM, 2001, CIRCULATION, V103, P919

[5] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .1. PROLONGED DIFFERENCES IN BLOOD-PRESSURE - PROSPECTIVE OBSERVATIONAL STUDIES CORRECTED FOR THE REGRESSION DILUTION BIAS [J].

MACMAHON, S ;

PETO, R ;

CUTLER, J ;

COLLINS, R ;

SORLIE, P ;

NEATON, J ;

ABBOTT, R ;

GODWIN, J ;

DYER, A ;

STAMLER, J .

LANCET, 1990, 335 (8692) :765-774

[6] Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease [J].

MacMahon, S ;

Sharpe, N ;

Gamble, G ;

Clague, A ;

Ni Mhurchu, C ;

Clark, T ;

Hart, H ;

Scott, J ;

White, H .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) :438-+

[7]

Neal B, 2000, LANCET, V356, P1955

[8]

PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556, DOI 10.1016/S0140-6736(01)06178-5

[9]

RODGERS A, 1997, NEUROL REV INT, V2, P12

[10]

Yusuf S, 2000, NEW ENGL J MED, V342, P145

← 1 →